9 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
Follow Epilepsy, Complex Partial: new trials by email Literature Review of Epilepsy, Complex Partial trials Research Report on Epilepsy, Complex Partial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures placebo, carisbamate - Epilepsy, Partial, Motor, Epilepsy, Complex Partial | Phase 3 | Completed | SK Life Science, Inc. | 403 | 2009-01-01 | 2013-06-18 |
| A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures. Carisbamate, placebo - Epilepsy, Partial, Motor, Epilepsy, Complex Partial | Phase 3 | Completed | SK Life Science, Inc. | 547 | 2009-01-01 | 2013-01-24 |
| Pregabalin Versus Levetiracetam In Partial Seizures pregabalin, levetiracetam - Partial Seizures | Phase 3 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 509 | 2007-10-01 | 2021-01-28 |
| An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures. carisbamate - Epilepsy, Complex Partial Seizures | Phase 3 | Completed | SK Life Science, Inc. | 991 | 2007-02-01 | 2013-06-18 |
| A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. RWJ-333369 - Epilepsy, Epilepsy, Focal | Phase 3 | Completed | SK Life Science, Inc. | 563 | 2006-11-01 | 2012-06-18 |
| A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. RWJ-333369 - Epilepsy, Epilepsy, Focal | Phase 3 | Completed | SK Life Science, Inc. | 566 | 2006-11-01 | 2012-06-20 |
| Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. Placebo, Vanquix Auto-Injector (Diazepam Injection) - Seizures, Epilepsies, Partial | Phase 3 | Completed | Pfizer | 234 | 2006-01-01 | 2016-09-23 |
| Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy Zonisamide - Epilepsy, Complex Partial | Phase 3 | Completed | Eisai Inc. | 165 | 2002-02-01 | 2011-07-18 |
| Pregabalin Open-Label Extension Trial in Patients With Partial Seizures Pregabalin - Epilepsies, Partial, Epilepsy, Complex Partial | Phase 3 | Completed | Pfizer | 300 | 2001-09-01 | 2006-07-24 |
Epilepsies, Partial (8) · Seizures (8) · Epilepsy (6) · Epilepsy, Partial, Motor (2) · Epilepsy, Generalized (1)
Brain Diseases (9) · Central Nervous System Diseases (9) · Nervous System Diseases (9) · Neurologic Manifestations (8) · Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Epilepsy (3) · Epilepsies, Partial (1)
S-2-O-carbamoyl-1-o-chlorophenyl-ethanol (5) · Pregabalin (2) · Diazepam (1) · Levetiracetam (1) · Zonisamide (1)
SK Life Science, Inc. (5) · Pfizer (2) · Eisai Inc. (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)
Lithuania (3) · France (2) · Germany (2) · Italy (2) · Spain (2) · United States (2) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Colombia (1) · Costa Rica (1) · Czechia (1) · Estonia (1) · Greece (1)
PMID 34870321, PMID 19863578, PMID 21320109, PMID 24111974, PMID 24902473